CYCLOPHOSPHAMIDE THERAPY IN ADULTS WITH MINIMAL-CHANGE NEPHROTIC SYNDROME

The Lancet

Volumn 299, Issue 7763, 1972, Pages 1250-1253

  Uldall, P R ^a   Feest, T G ^a   Morley, A R ^a   Tomlinson, B E ^a   Kerr, D N S ^a  

^a NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CYCLOPHOSPHAMIDE; SERUM ALBUMIN; STEROID;

ADOLESCENT; ADULT; AMENORRHEA; ARTICLE; BLOOD; CLINICAL TRIAL; FEMALE; HUMAN; LEUKOCYTE COUNT; MALE; MICROSCOPY; NEPHROTIC SYNDROME; PATHOLOGY; PROTEINURIA; REMISSION; TIME; URINE;

ADOLESCENT; ADULT; AMENORRHEA; CHOLESTEROL; CLINICAL TRIALS; CYCLOPHOSPHAMIDE; FEMALE; HUMAN; LEUKOCYTE COUNT; MALE; MICROSCOPY; MIDDLE AGE; NEPHROTIC SYNDROME; PROTEINURIA; REMISSION, SPONTANEOUS; SERUM ALBUMIN; STEROIDS; TIME FACTORS;

EID: 0015501099     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(72)90978-6     Document Type: Article

References (23)

1. Controlled Trial of Azathioprine and Prednisone in Chronic Renal Disease
2. Vascular Complications in Nephrotic Syndrome: Relationship to Steroid Therapy and Accelerated Thromboplastin Generation
3. Paired Trial of Cyclophosphamide and Prednisone in Children with Nephrosis